Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis have?
Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis has 324 citations in the OpenAlex counts ScholarIQ stores.
When was Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis published?
Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis has 2015 year in the ScholarIQ index.
What is the open-access status of Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis?
Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis has closed oa status in the ScholarIQ index.
What is the DOI of Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis?
The DOI for Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis is on the source record.
What is the PMID of Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis?
The PMID for Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis is on the source record.
What is the OpenAlex record for Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis?
The OpenAlex for Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis is on the source record.